secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0001193125-22-294013
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma confirms VOR33 engraftment and hematological protection data to be announced later this year
--------------------------------------------------------------------------------

- Vor Biopharma presented at Piper Sandler 34th Annual Healthcare Conference on November 29, 2022.
- Company confirmed upcoming VOR33 data will include engraftment data and hematological protection data.
- Data follows treatment with Mylotarg in at least one patient.
- VOR33 data expected to be announced later this year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/0001193125-22-294013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/d426366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-294013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer